当身体变得沉默时:一个关于肌缩侧面硬化症的病例报告
Marta Pereira de Oliveira1, Filomena Lima Monteiro1
1Family Medicine, USF Ars Médica, Lisboa, PRT.
Cureus
|November 27, 2025
概括
本案例研究详细介绍了一名49岁的男子,在手腕受伤后被诊断出患有早期发生的肌缩侧面硬化症 (ALS). 它强调了在进展性神经肌肉症状和多学科护理中需要临床怀疑.
科学领域:
- 神经学 神经学
- 神经退行性疾病 神经退行性疾病
- 运动神经元疾病 运动神经元疾病
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,影响运动神经元.
- 它会导致肌肉衰弱,缩和最终的呼吸衰竭.
- 早期发病的ALS在诊断和管理方面存在独特的挑战.
研究的目的:
- 在初始手腕受伤后诊断出早期发病的ALS病例.
- 要突出诊断挑战和ALS的快速进展.
- 强调多学科护理和初级保健参与的重要性.
主要方法:
- 一个49岁的男性患者的病例报告.
- 在手腕受伤初步GP评估后,在急诊室开始诊断工作.
- 电肌图 (EMG) 用于评估神经性变化.
- 通过补充诊断研究排除替代病因.
主要成果:
- 在2023年9月确立ALS诊断.
- 电磁共振显现出具有急性和慢性神经性变化的广泛变质.
- 患者接受了Riluzole治疗和17个月的多学科管理.
- 观察到疾病的快速进展,在2025年2月死亡.
结论:
- 早期发病的ALS可以潜伏地呈现,需要高度的临床怀疑进展的神经肌肉症状.
- 多学科管理,早期息治疗和强有力的初级保健支持对于优化患者和家庭福祉至关重要.
- 这一案例强调了一些ALS病例的破坏性影响和快速进展的特征.
相关概念视频
Cross-bridge Cycle
122.0K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
122.0K
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K


